{
    "SPADE_UN_18958": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18958",
            "Peptide Name": "SF (synthetic AMPs, conjugated peptide: staph-targeting sequence + temporin-SHf, XXA, UCLL1c)",
            "Source": "Designed, peptide conjugate, peptide hybrid",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "SYWVRASGGGFFFLSRIF",
            "Sequence Length": 18,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2097.37,
            "PI": 10.83,
            "Hydrophobicity": 0.59,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Wang T, Tan P, Tang Q, Zhou C, Ding Y, Xu S, Song M, Fu H, Zhang Y, Zhang X, Bai Y, Sun Z, Ma X. 2024",
                    "Reference": "mLife. 2024 May 27;3(2):251-268. doi: 10.1002/mlf2.12123.PubMed",
                    "Title": "Phage-displayed heptapeptide sequence conjugation significantly improves the specific targeting ability of antimicrobial peptides against Staphylococcus aureus."
                }
            ],
            "Frequent Amino Acids": "FGS",
            "Absent Amino Acids": "CDEHKMNOPQTU",
            "Basic Residues": 2,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 10,
            "Polar Residues": 8,
            "Positive Residues": 2,
            "Negative Residues": 0,
            "Net Charge": 2,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (44.44%) toTemporin-SHfF: 22%, G=S: 17%, R: 11%.Nomenclature: named by taking the first amino acid S in the targeting sequence and the first amino acid F of temporin-SHf.Activity: Active against S. aureus 1882 or 6538 (MIC 2-16 uM), S-epidermidis 12228 (MIC > 64 uM), E-coli 25922 or K88 or K99 (MIC > 64 uM), P-aeruginosa 27853 or 15442 (MIC > 64 uM).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_15509",
                    "Similarity": 1.0,
                    "Sequence": "SYWVRASGGGFFFLSRIFRRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_18959",
                    "Similarity": 1.0,
                    "Sequence": "SYWVRASGGGFFFLSRIFR"
                },
                {
                    "SPADE_ID": "SPADE_UN_18960",
                    "Similarity": 1.0,
                    "Sequence": "SYWVRASGGGFFFLSRIFK"
                }
            ]
        }
    }
}